Skip to main content
Top
Published in: Journal of Cardiovascular Translational Research 2/2014

01-03-2014

Coagulation, Protease-Activated Receptors, and Viral Myocarditis

Authors: Silvio Antoniak, Nigel Mackman

Published in: Journal of Cardiovascular Translational Research | Issue 2/2014

Login to get access

Abstract

The coagulation protease cascade plays an essential role in hemostasis. In addition, a clot contributes to host defense by limiting the spread of pathogens. Coagulation proteases induce intracellular signaling by cleavage of cell surface receptors called protease-activated receptors (PARs). These receptors allow cells to sense changes in the extracellular environment, such as infection. Viruses activate the coagulation cascade by inducing tissue factor expression and by disrupting the endothelium. Virus infection of the heart can cause myocarditis, cardiac remodeling, and heart failure. A recent study using a mouse model have shown that tissue factor, thrombin, and PAR-1 signaling all positively regulate the innate immune during viral myocarditis. In contrast, PAR-2 signaling was found to inhibit interferon-β expression and the innate immune response. These observations suggest that anticoagulants may impair the innate immune response to viral infection and that inhibition of PAR-2 may be a new strategy to reduce viral myocarditis.
Literature
1.
go back to reference Shauer, A., Gotsman, I., Keren, A., Zwas, D. R., Hellman, Y., Durst, R., et al. (2013). Acute viral myocarditis: current concepts in diagnosis and treatment. The Israel Medical Association journal : IMAJ, 15(3), 180–185.PubMed Shauer, A., Gotsman, I., Keren, A., Zwas, D. R., Hellman, Y., Durst, R., et al. (2013). Acute viral myocarditis: current concepts in diagnosis and treatment. The Israel Medical Association journal : IMAJ, 15(3), 180–185.PubMed
3.
go back to reference Liu, P. P., & Mason, J. W. (2001). Advances in the understanding of myocarditis. Circulation, 104(9), 1076–1082.PubMed Liu, P. P., & Mason, J. W. (2001). Advances in the understanding of myocarditis. Circulation, 104(9), 1076–1082.PubMed
4.
go back to reference Antoniak, S., Boltzen, U., Riad, A., Kallwellis-Opara, A., Rohde, M., Dorner, A., et al. (2008). Viral myocarditis and coagulopathy: increased tissue factor expression and plasma thrombogenicity. Journal of molecular and cellular cardiology, 45(1), 118–126. doi:10.1016/j.yjmcc.2008.03.013.PubMed Antoniak, S., Boltzen, U., Riad, A., Kallwellis-Opara, A., Rohde, M., Dorner, A., et al. (2008). Viral myocarditis and coagulopathy: increased tissue factor expression and plasma thrombogenicity. Journal of molecular and cellular cardiology, 45(1), 118–126. doi:10.​1016/​j.​yjmcc.​2008.​03.​013.PubMed
9.
go back to reference Huber, S. (2008). Host immune responses to coxsackievirus B3. Current topics in microbiology and immunology, 323, 199–221.PubMed Huber, S. (2008). Host immune responses to coxsackievirus B3. Current topics in microbiology and immunology, 323, 199–221.PubMed
11.
go back to reference Leipner, C., Grun, K., Schneider, I., Gluck, B., Sigusch, H. H., & Stelzner, A. (2004). Coxsackievirus B3-induced myocarditis: differences in the immune response of C57BL/6 and Balb/c mice. Medical microbiology and immunology, 193(2–3), 141–147. doi:10.1007/s00430-003-0199-5.PubMed Leipner, C., Grun, K., Schneider, I., Gluck, B., Sigusch, H. H., & Stelzner, A. (2004). Coxsackievirus B3-induced myocarditis: differences in the immune response of C57BL/6 and Balb/c mice. Medical microbiology and immunology, 193(2–3), 141–147. doi:10.​1007/​s00430-003-0199-5.PubMed
12.
go back to reference Weinzierl, A. O., Szalay, G., Wolburg, H., Sauter, M., Rammensee, H. G., Kandolf, R., et al. (2008). Effective chemokine secretion by dendritic cells and expansion of cross-presenting CD4-/CD8+ dendritic cells define a protective phenotype in the mouse model of coxsackievirus myocarditis. Journal of virology, 82(16), 8149–8160. doi:10.1128/JVI.00047-08.PubMedCentralPubMed Weinzierl, A. O., Szalay, G., Wolburg, H., Sauter, M., Rammensee, H. G., Kandolf, R., et al. (2008). Effective chemokine secretion by dendritic cells and expansion of cross-presenting CD4-/CD8+ dendritic cells define a protective phenotype in the mouse model of coxsackievirus myocarditis. Journal of virology, 82(16), 8149–8160. doi:10.​1128/​JVI.​00047-08.PubMedCentralPubMed
13.
go back to reference Negishi, H., Osawa, T., Ogami, K., Ouyang, X., Sakaguchi, S., Koshiba, R., et al. (2008). A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity. Proceedings of the National Academy of Sciences of the United States of America, 105(51), 20446–20451. doi:10.1073/pnas.0810372105.PubMedCentralPubMed Negishi, H., Osawa, T., Ogami, K., Ouyang, X., Sakaguchi, S., Koshiba, R., et al. (2008). A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity. Proceedings of the National Academy of Sciences of the United States of America, 105(51), 20446–20451. doi:10.​1073/​pnas.​0810372105.PubMedCentralPubMed
15.
go back to reference Abston, E. D., Coronado, M. J., Bucek, A., Bedja, D., Shin, J., Kim, J. B., et al. (2012). Th2 regulation of viral myocarditis in mice: different roles for TLR3 versus TRIF in progression to chronic disease. Clinical & developmental immunology, 2012, 129486. doi:10.1155/2012/129486. Abston, E. D., Coronado, M. J., Bucek, A., Bedja, D., Shin, J., Kim, J. B., et al. (2012). Th2 regulation of viral myocarditis in mice: different roles for TLR3 versus TRIF in progression to chronic disease. Clinical & developmental immunology, 2012, 129486. doi:10.​1155/​2012/​129486.
16.
go back to reference Riad, A., Westermann, D., Zietsch, C., Savvatis, K., Becher, P. M., Bereswill, S., et al. (2011). TRIF is a critical survival factor in viral cardiomyopathy. Journal of Immunology, 186(4), 2561–2570. doi:10.4049/jimmunol.1002029. Riad, A., Westermann, D., Zietsch, C., Savvatis, K., Becher, P. M., Bereswill, S., et al. (2011). TRIF is a critical survival factor in viral cardiomyopathy. Journal of Immunology, 186(4), 2561–2570. doi:10.​4049/​jimmunol.​1002029.
17.
go back to reference Newman, K. C., & Riley, E. M. (2007). Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens. Nature reviews Immunology, 7(4), 279–291. doi:10.1038/nri2057.PubMed Newman, K. C., & Riley, E. M. (2007). Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens. Nature reviews Immunology, 7(4), 279–291. doi:10.​1038/​nri2057.PubMed
18.
go back to reference Wessely, R., Klingel, K., Knowlton, K. U., & Kandolf, R. (2001). Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication. Circulation, 103(5), 756–761.PubMed Wessely, R., Klingel, K., Knowlton, K. U., & Kandolf, R. (2001). Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication. Circulation, 103(5), 756–761.PubMed
20.
go back to reference Kuhl, U., Pauschinger, M., Schwimmbeck, P. L., Seeberg, B., Lober, C., Noutsias, M., et al. (2003). Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation, 107(22), 2793–2798. doi:10.1161/01.CIR.0000072766.67150.51.PubMed Kuhl, U., Pauschinger, M., Schwimmbeck, P. L., Seeberg, B., Lober, C., Noutsias, M., et al. (2003). Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation, 107(22), 2793–2798. doi:10.​1161/​01.​CIR.​0000072766.​67150.​51.PubMed
21.
go back to reference Wang, Y. X., da Cunha, V., Vincelette, J., White, K., Velichko, S., Xu, Y., et al. (2007). Antiviral and myocyte protective effects of murine interferon-beta and -{alpha}2 in coxsackievirus B3-induced myocarditis and epicarditis in Balb/c mice. American journal of physiology Heart and circulatory physiology, 293(1), H69–76. doi:10.1152/ajpheart.00154.2007.PubMed Wang, Y. X., da Cunha, V., Vincelette, J., White, K., Velichko, S., Xu, Y., et al. (2007). Antiviral and myocyte protective effects of murine interferon-beta and -{alpha}2 in coxsackievirus B3-induced myocarditis and epicarditis in Balb/c mice. American journal of physiology Heart and circulatory physiology, 293(1), H69–76. doi:10.​1152/​ajpheart.​00154.​2007.PubMed
22.
go back to reference Kuhl, U., Lassner, D., von Schlippenbach, J., Poller, W., & Schultheiss, H. P. (2012). Interferon-beta improves survival in enterovirus-associated cardiomyopathy. Journal of the American College of Cardiology, 60(14), 1295–1296. doi:10.1016/j.jacc.2012.06.026.PubMed Kuhl, U., Lassner, D., von Schlippenbach, J., Poller, W., & Schultheiss, H. P. (2012). Interferon-beta improves survival in enterovirus-associated cardiomyopathy. Journal of the American College of Cardiology, 60(14), 1295–1296. doi:10.​1016/​j.​jacc.​2012.​06.​026.PubMed
24.
go back to reference Yuan, J., Liu, Z., Lim, T., Zhang, H., He, J., Walker, E., et al. (2009). CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis. Circulation research, 104(5), 628–638. doi:10.1161/CIRCRESAHA.108.192179.PubMed Yuan, J., Liu, Z., Lim, T., Zhang, H., He, J., Walker, E., et al. (2009). CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis. Circulation research, 104(5), 628–638. doi:10.​1161/​CIRCRESAHA.​108.​192179.PubMed
25.
go back to reference Godeny, E. K., & Gauntt, C. J. (1987). Murine natural killer cells limit coxsackievirus B3 replication. Journal of Immunology, 139(3), 913–918. Godeny, E. K., & Gauntt, C. J. (1987). Murine natural killer cells limit coxsackievirus B3 replication. Journal of Immunology, 139(3), 913–918.
27.
go back to reference Drake, T. A., Morrissey, J. H., & Edgington, T. S. (1989). Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. The American journal of pathology, 134(5), 1087–1097.PubMed Drake, T. A., Morrissey, J. H., & Edgington, T. S. (1989). Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. The American journal of pathology, 134(5), 1087–1097.PubMed
28.
go back to reference Fleck, R. A., Rao, L. V., Rapaport, S. I., & Varki, N. (1990). Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thrombosis research, 59(2), 421–437.PubMed Fleck, R. A., Rao, L. V., Rapaport, S. I., & Varki, N. (1990). Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thrombosis research, 59(2), 421–437.PubMed
31.
go back to reference Flick, M. J., Du, X., Witte, D. P., Jirouskova, M., Soloviev, D. A., Busuttil, S. J., et al. (2004). Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo. The Journal of clinical investigation, 113(11), 1596–1606. doi:10.1172/JCI20741.PubMedCentralPubMed Flick, M. J., Du, X., Witte, D. P., Jirouskova, M., Soloviev, D. A., Busuttil, S. J., et al. (2004). Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo. The Journal of clinical investigation, 113(11), 1596–1606. doi:10.​1172/​JCI20741.PubMedCentralPubMed
32.
go back to reference Palumbo, J. S., Talmage, K. E., Massari, J. V., La Jeunesse, C. M., Flick, M. J., Kombrinck, K. W., et al. (2005). Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood, 105(1), 178–185. doi:10.1182/blood-2004-06-2272.PubMed Palumbo, J. S., Talmage, K. E., Massari, J. V., La Jeunesse, C. M., Flick, M. J., Kombrinck, K. W., et al. (2005). Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood, 105(1), 178–185. doi:10.​1182/​blood-2004-06-2272.PubMed
33.
go back to reference Key, N. S., Vercellotti, G. M., Winkelmann, J. C., Moldow, C. F., Goodman, J. L., Esmon, N. L., et al. (1990). Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression. Proceedings of the National Academy of Sciences of the United States of America, 87(18), 7095–7099.PubMedCentralPubMed Key, N. S., Vercellotti, G. M., Winkelmann, J. C., Moldow, C. F., Goodman, J. L., Esmon, N. L., et al. (1990). Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression. Proceedings of the National Academy of Sciences of the United States of America, 87(18), 7095–7099.PubMedCentralPubMed
34.
go back to reference Geisbert, T. W., Young, H. A., Jahrling, P. B., Davis, K. J., Kagan, E., & Hensley, L. E. (2003). Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. The Journal of infectious diseases, 188(11), 1618–1629. doi:10.1086/379724.PubMed Geisbert, T. W., Young, H. A., Jahrling, P. B., Davis, K. J., Kagan, E., & Hensley, L. E. (2003). Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. The Journal of infectious diseases, 188(11), 1618–1629. doi:10.​1086/​379724.PubMed
35.
go back to reference Goeijenbier, M., van Wissen, M., van de Weg, C., Jong, E., Gerdes, V. E., Meijers, J. C., et al. (2012). Review: viral infections and mechanisms of thrombosis and bleeding. Journal of medical virology, 84(10), 1680–1696. doi:10.1002/jmv.23354.PubMed Goeijenbier, M., van Wissen, M., van de Weg, C., Jong, E., Gerdes, V. E., Meijers, J. C., et al. (2012). Review: viral infections and mechanisms of thrombosis and bleeding. Journal of medical virology, 84(10), 1680–1696. doi:10.​1002/​jmv.​23354.PubMed
36.
go back to reference Funderburg, N. T., Mayne, E., Sieg, S. F., Asaad, R., Jiang, W., Kalinowska, M., et al. (2010). Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation. Blood, 115(2), 161–167. doi:10.1182/blood-2009-03-210179.PubMed Funderburg, N. T., Mayne, E., Sieg, S. F., Asaad, R., Jiang, W., Kalinowska, M., et al. (2010). Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation. Blood, 115(2), 161–167. doi:10.​1182/​blood-2009-03-210179.PubMed
37.
go back to reference Antoniak, S., Owens, A. P., 3rd, Baunacke, M., Williams, J. C., Lee, R. D., Weithauser, A., et al. (2013). PAR-1 contributes to the innate immune response during viral infection. The Journal of clinical investigation, 123(3), 1310–1322. doi:10.1172/JCI66125.PubMedCentralPubMed Antoniak, S., Owens, A. P., 3rd, Baunacke, M., Williams, J. C., Lee, R. D., Weithauser, A., et al. (2013). PAR-1 contributes to the innate immune response during viral infection. The Journal of clinical investigation, 123(3), 1310–1322. doi:10.​1172/​JCI66125.PubMedCentralPubMed
38.
go back to reference Shibamiya, A., Hersemeyer, K., Schmidt Woll, T., Sedding, D., Daniel, J. M., Bauer, S., et al. (2009). A key role for Toll-like receptor-3 in disrupting the hemostasis balance on endothelial cells. Blood, 113(3), 714–722. doi:10.1182/blood-2008-02-137901.PubMed Shibamiya, A., Hersemeyer, K., Schmidt Woll, T., Sedding, D., Daniel, J. M., Bauer, S., et al. (2009). A key role for Toll-like receptor-3 in disrupting the hemostasis balance on endothelial cells. Blood, 113(3), 714–722. doi:10.​1182/​blood-2008-02-137901.PubMed
39.
go back to reference Zare, F., Magnusson, M., Mollers, L. N., Jin, T., Tarkowski, A., & Bokarewa, M. (2008). Single-stranded polyinosinic acid oligonucleotides trigger leukocyte production of proteins belonging to fibrinolytic and coagulation cascades. Journal of leukocyte biology, 84(3), 741–747. doi:10.1189/jlb.0506345.PubMed Zare, F., Magnusson, M., Mollers, L. N., Jin, T., Tarkowski, A., & Bokarewa, M. (2008). Single-stranded polyinosinic acid oligonucleotides trigger leukocyte production of proteins belonging to fibrinolytic and coagulation cascades. Journal of leukocyte biology, 84(3), 741–747. doi:10.​1189/​jlb.​0506345.PubMed
40.
go back to reference Kato, J., Okamoto, T., Motoyama, H., Uchiyama, R., Kirchhofer, D., Van Rooijen, N., et al. (2013). Interferon-gamma-mediated tissue factor expression contributes to T-cell-mediated hepatitis through induction of hypercoagulation in mice. Hepatology, 57(1), 362–372. doi:10.1002/hep.26027.PubMed Kato, J., Okamoto, T., Motoyama, H., Uchiyama, R., Kirchhofer, D., Van Rooijen, N., et al. (2013). Interferon-gamma-mediated tissue factor expression contributes to T-cell-mediated hepatitis through induction of hypercoagulation in mice. Hepatology, 57(1), 362–372. doi:10.​1002/​hep.​26027.PubMed
41.
go back to reference Bhattacharyya, M., Karmohapatra, S. K., Bhattacharya, G., Bhattacharya, R., & Sinha, A. K. (2009). The role of leucocytes in the acetyl salicylic acid (aspirin) induced nitric oxide synthesis in the production of interferon-alpha, a potent inhibitor of platelet aggregation and a thrombolytic agent. Journal of thrombosis and thrombolysis, 28(2), 173–184. doi:10.1007/s11239-008-0283-1.PubMed Bhattacharyya, M., Karmohapatra, S. K., Bhattacharya, G., Bhattacharya, R., & Sinha, A. K. (2009). The role of leucocytes in the acetyl salicylic acid (aspirin) induced nitric oxide synthesis in the production of interferon-alpha, a potent inhibitor of platelet aggregation and a thrombolytic agent. Journal of thrombosis and thrombolysis, 28(2), 173–184. doi:10.​1007/​s11239-008-0283-1.PubMed
42.
go back to reference Antoniak, S., Boltzen, U., Eisenreich, A., Stellbaum, C., Poller, W., Schultheiss, H. P., et al. (2009). Regulation of cardiomyocyte full-length tissue factor expression and microparticle release under inflammatory conditions in vitro. Journal of thrombosis and haemostasis : JTH, 7(5), 871–878. doi:10.1111/j.1538-7836.2009.03323.x.PubMed Antoniak, S., Boltzen, U., Eisenreich, A., Stellbaum, C., Poller, W., Schultheiss, H. P., et al. (2009). Regulation of cardiomyocyte full-length tissue factor expression and microparticle release under inflammatory conditions in vitro. Journal of thrombosis and haemostasis : JTH, 7(5), 871–878. doi:10.​1111/​j.​1538-7836.​2009.​03323.​x.PubMed
43.
go back to reference Tomioka, N., Kishimoto, C., Matsumori, A., & Kawai, C. (1985). Mural thrombi in mice with acute viral myocarditis. Japanese circulation journal, 49(12), 1277–1279.PubMed Tomioka, N., Kishimoto, C., Matsumori, A., & Kawai, C. (1985). Mural thrombi in mice with acute viral myocarditis. Japanese circulation journal, 49(12), 1277–1279.PubMed
44.
go back to reference Kojima, J., Miyazaki, S., Fujiwara, H., Kumada, T., & Kawai, C. (1988). Recurrent left ventricular mural thrombi in a patient with acute myocarditis. Heart and vessels, 4(2), 120–122.PubMed Kojima, J., Miyazaki, S., Fujiwara, H., Kumada, T., & Kawai, C. (1988). Recurrent left ventricular mural thrombi in a patient with acute myocarditis. Heart and vessels, 4(2), 120–122.PubMed
45.
go back to reference Mazza, I. L., Jacobs, J. P., Aldousany, A., Chang, A. C., & Burke, R. P. (1998). Video-assisted cardioscopy for left ventricular thrombectomy in a child. The Annals of thoracic surgery, 66(1), 248–250.PubMed Mazza, I. L., Jacobs, J. P., Aldousany, A., Chang, A. C., & Burke, R. P. (1998). Video-assisted cardioscopy for left ventricular thrombectomy in a child. The Annals of thoracic surgery, 66(1), 248–250.PubMed
46.
go back to reference Weikert, U., Rauch, U., Kuhl, U., Hohmann, C., Jaster, M., Pauschinger, M., et al. (2002). Increased thrombocyte activation in dilated cardiomyopathy: a risk factor for development of ventricular thrombosis despite anticoagulant therapy? Zeitschrift für Kardiologie, 91(5), 423–429.PubMed Weikert, U., Rauch, U., Kuhl, U., Hohmann, C., Jaster, M., Pauschinger, M., et al. (2002). Increased thrombocyte activation in dilated cardiomyopathy: a risk factor for development of ventricular thrombosis despite anticoagulant therapy? Zeitschrift für Kardiologie, 91(5), 423–429.PubMed
47.
go back to reference Miyamoto, K., Yasuda, S., Noguchi, T., Tanimoto, T., Kakuchi, H., Morii, I., et al. (2005). Fulminant myocarditis causing severe left heart failure and massive thrombus formation following cardiac tamponade: a case report. Journal of cardiology, 46(1), 25–31.PubMed Miyamoto, K., Yasuda, S., Noguchi, T., Tanimoto, T., Kakuchi, H., Morii, I., et al. (2005). Fulminant myocarditis causing severe left heart failure and massive thrombus formation following cardiac tamponade: a case report. Journal of cardiology, 46(1), 25–31.PubMed
49.
go back to reference Lin, K. Y., Kerur, B., Witmer, C. M., Beslow, L. A., Licht, D. J., Ichord, R. N., & Kaufman, B. D. (2013). Thrombotic events in critically ill children with myocarditis. Cardiology in the Young, 9, 1–8. doi:10.1017/S1047951113001145. Lin, K. Y., Kerur, B., Witmer, C. M., Beslow, L. A., Licht, D. J., Ichord, R. N., & Kaufman, B. D. (2013). Thrombotic events in critically ill children with myocarditis. Cardiology in the Young, 9, 1–8. doi:10.​1017/​S104795111300114​5.
50.
go back to reference Gottdiener, J. S., Gay, J. A., VanVoorhees, L., DiBianco, R., & Fletcher, R. D. (1983). Frequency and embolic potential of left ventricular thrombus in dilated cardiomyopathy: assessment by 2-dimensional echocardiography. The American journal of cardiology, 52(10), 1281–1285.PubMed Gottdiener, J. S., Gay, J. A., VanVoorhees, L., DiBianco, R., & Fletcher, R. D. (1983). Frequency and embolic potential of left ventricular thrombus in dilated cardiomyopathy: assessment by 2-dimensional echocardiography. The American journal of cardiology, 52(10), 1281–1285.PubMed
51.
go back to reference Tomioka, N., Kishimoto, C., Matsumori, A., & Kawai, C. (1986). Mural thrombus in experimental viral myocarditis in mice: relation between thrombosis and congestive heart failure. Cardiovascular research, 20(9), 665–671.PubMed Tomioka, N., Kishimoto, C., Matsumori, A., & Kawai, C. (1986). Mural thrombus in experimental viral myocarditis in mice: relation between thrombosis and congestive heart failure. Cardiovascular research, 20(9), 665–671.PubMed
52.
go back to reference Kishimoto, C., Ochiai, H., & Sasayama, S. (1992). Intracardiac thrombus in murine coxsackievirus B3 myocarditis. Heart and vessels, 7(2), 76–81.PubMed Kishimoto, C., Ochiai, H., & Sasayama, S. (1992). Intracardiac thrombus in murine coxsackievirus B3 myocarditis. Heart and vessels, 7(2), 76–81.PubMed
53.
go back to reference Nakamura, Y., Nakamura, K., Fukushima-Kusano, K., Ohta, K., Matsubara, H., Hamuro, T., et al. (2003). Tissue factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: possible involvement in intracardiac thrombogenesis. Thrombosis research, 111(3), 137–142.PubMed Nakamura, Y., Nakamura, K., Fukushima-Kusano, K., Ohta, K., Matsubara, H., Hamuro, T., et al. (2003). Tissue factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: possible involvement in intracardiac thrombogenesis. Thrombosis research, 111(3), 137–142.PubMed
54.
go back to reference Szotowski, B., Goldin-Lang, P., Antoniak, S., Bogdanov, V. Y., Pathirana, D., Pauschinger, M., et al. (2005). Alterations in myocardial tissue factor expression and cellular localization in dilated cardiomyopathy. Journal of the American College of Cardiology, 45(7), 1081–1089. doi:10.1016/j.jacc.2004.12.061.PubMed Szotowski, B., Goldin-Lang, P., Antoniak, S., Bogdanov, V. Y., Pathirana, D., Pauschinger, M., et al. (2005). Alterations in myocardial tissue factor expression and cellular localization in dilated cardiomyopathy. Journal of the American College of Cardiology, 45(7), 1081–1089. doi:10.​1016/​j.​jacc.​2004.​12.​061.PubMed
55.
go back to reference Weikert, U., Kuhl, U., Schultheiss, H. P., & Rauch, U. (2002). Platelet activation is increased in patients with cardiomyopathy: myocardial inflammation and platelet reactivity. Platelets, 13(8), 487–491. doi:10.1080/0953710021000057857.PubMed Weikert, U., Kuhl, U., Schultheiss, H. P., & Rauch, U. (2002). Platelet activation is increased in patients with cardiomyopathy: myocardial inflammation and platelet reactivity. Platelets, 13(8), 487–491. doi:10.​1080/​0953710021000057​857.PubMed
56.
go back to reference Schnitt, S. J., Stillman, I. E., Owings, D. V., Kishimoto, C., Dvorak, H. F., & Abelmann, W. H. (1993). Myocardial fibrin deposition in experimental viral myocarditis that progresses to dilated cardiomyopathy. Circulation research, 72(4), 914–920.PubMed Schnitt, S. J., Stillman, I. E., Owings, D. V., Kishimoto, C., Dvorak, H. F., & Abelmann, W. H. (1993). Myocardial fibrin deposition in experimental viral myocarditis that progresses to dilated cardiomyopathy. Circulation research, 72(4), 914–920.PubMed
57.
go back to reference Frizelle, S., Schwarz, J., Huber, S. A., & Leslie, K. (1992). Evaluation of the effects of low molecular weight heparin on inflammation and collagen deposition in chronic coxsackievirus B3-induced myocarditis in A/J mice. The American journal of pathology, 141(1), 203–209.PubMed Frizelle, S., Schwarz, J., Huber, S. A., & Leslie, K. (1992). Evaluation of the effects of low molecular weight heparin on inflammation and collagen deposition in chronic coxsackievirus B3-induced myocarditis in A/J mice. The American journal of pathology, 141(1), 203–209.PubMed
58.
62.
go back to reference Kahn, M. L., Zheng, Y. W., Huang, W., Bigornia, V., Zeng, D., Moff, S., et al. (1998). A dual thrombin receptor system for platelet activation. Nature, 394(6694), 690–694. doi:10.1038/29325.PubMed Kahn, M. L., Zheng, Y. W., Huang, W., Bigornia, V., Zeng, D., Moff, S., et al. (1998). A dual thrombin receptor system for platelet activation. Nature, 394(6694), 690–694. doi:10.​1038/​29325.PubMed
63.
go back to reference Steinhoff, M., Buddenkotte, J., Shpacovitch, V., Rattenholl, A., Moormann, C., Vergnolle, N., et al. (2005). Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocrine reviews, 26(1), 1–43. doi:10.1210/er.2003-0025.PubMed Steinhoff, M., Buddenkotte, J., Shpacovitch, V., Rattenholl, A., Moormann, C., Vergnolle, N., et al. (2005). Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocrine reviews, 26(1), 1–43. doi:10.​1210/​er.​2003-0025.PubMed
65.
go back to reference Moretti, S., Bellocchio, S., Bonifazi, P., Bozza, S., Zelante, T., Bistoni, F., et al. (2008). The contribution of PARs to inflammation and immunity to fungi. Mucosal immunology, 1(2), 156–168. doi:10.1038/mi.2007.13.PubMed Moretti, S., Bellocchio, S., Bonifazi, P., Bozza, S., Zelante, T., Bistoni, F., et al. (2008). The contribution of PARs to inflammation and immunity to fungi. Mucosal immunology, 1(2), 156–168. doi:10.​1038/​mi.​2007.​13.PubMed
66.
go back to reference Day, J. R., Landis, R. C., & Taylor, K. M. (2006). Aprotinin and the protease-activated receptor 1 thrombin receptor: antithrombosis, inflammation, and stroke reduction. Seminars in cardiothoracic and vascular anesthesia, 10(2), 132–142. doi:10.1177/1089253206288997.PubMed Day, J. R., Landis, R. C., & Taylor, K. M. (2006). Aprotinin and the protease-activated receptor 1 thrombin receptor: antithrombosis, inflammation, and stroke reduction. Seminars in cardiothoracic and vascular anesthesia, 10(2), 132–142. doi:10.​1177/​1089253206288997​.PubMed
67.
go back to reference Pan, H. Y., Yamada, H., Chida, J., Wang, S., Yano, M., Yao, M., et al. (2011). Up-regulation of ectopic trypsins in the myocardium by influenza A virus infection triggers acute myocarditis. Cardiovascular research, 89(3), 595–603. doi:10.1093/cvr/cvq358.PubMed Pan, H. Y., Yamada, H., Chida, J., Wang, S., Yano, M., Yao, M., et al. (2011). Up-regulation of ectopic trypsins in the myocardium by influenza A virus infection triggers acute myocarditis. Cardiovascular research, 89(3), 595–603. doi:10.​1093/​cvr/​cvq358.PubMed
68.
go back to reference Pan, H. Y., Yano, M., & Kido, H. (2011). Effects of inhibitors of Toll-like receptors, protease-activated receptor-2 signalings and trypsin on influenza A virus replication and upregulation of cellular factors in cardiomyocytes. The journal of medical investigation : JMI, 58(1–2), 19–28.PubMed Pan, H. Y., Yano, M., & Kido, H. (2011). Effects of inhibitors of Toll-like receptors, protease-activated receptor-2 signalings and trypsin on influenza A virus replication and upregulation of cellular factors in cardiomyocytes. The journal of medical investigation : JMI, 58(1–2), 19–28.PubMed
69.
go back to reference Seitz, C., Isken, B., Heynisch, B., Rettkowski, M., Frensing, T., & Reichl, U. (2012). Trypsin promotes efficient influenza vaccine production in MDCK cells by interfering with the antiviral host response. Applied microbiology and biotechnology, 93(2), 601–611. doi:10.1007/s00253-011-3569-8.PubMed Seitz, C., Isken, B., Heynisch, B., Rettkowski, M., Frensing, T., & Reichl, U. (2012). Trypsin promotes efficient influenza vaccine production in MDCK cells by interfering with the antiviral host response. Applied microbiology and biotechnology, 93(2), 601–611. doi:10.​1007/​s00253-011-3569-8.PubMed
70.
go back to reference Sun, X., Tse, L. V., Ferguson, A. D., & Whittaker, G. R. (2010). Modifications to the hemagglutinin cleavage site control the virulence of a neurotropic H1N1 influenza virus. Journal of virology, 84(17), 8683–8690. doi:10.1128/JVI.00797-10.PubMedCentralPubMed Sun, X., Tse, L. V., Ferguson, A. D., & Whittaker, G. R. (2010). Modifications to the hemagglutinin cleavage site control the virulence of a neurotropic H1N1 influenza virus. Journal of virology, 84(17), 8683–8690. doi:10.​1128/​JVI.​00797-10.PubMedCentralPubMed
71.
go back to reference Gomides, L. F., Duarte, I. D., Ferreira, R. G., Perez, A. C., Francischi, J. N., & Klein, A. (2012). Proteinase-activated receptor-4 plays a major role in the recruitment of neutrophils induced by trypsin or carrageenan during pleurisy in mice. Pharmacology, 89(5–6), 275–282. doi:10.1159/000337378.PubMed Gomides, L. F., Duarte, I. D., Ferreira, R. G., Perez, A. C., Francischi, J. N., & Klein, A. (2012). Proteinase-activated receptor-4 plays a major role in the recruitment of neutrophils induced by trypsin or carrageenan during pleurisy in mice. Pharmacology, 89(5–6), 275–282. doi:10.​1159/​000337378.PubMed
72.
go back to reference Sambrano, G. R., Huang, W., Faruqi, T., Mahrus, S., Craik, C., & Coughlin, S. R. (2000). Cathepsin G activates protease-activated receptor-4 in human platelets. The Journal of biological chemistry, 275(10), 6819–6823.PubMed Sambrano, G. R., Huang, W., Faruqi, T., Mahrus, S., Craik, C., & Coughlin, S. R. (2000). Cathepsin G activates protease-activated receptor-4 in human platelets. The Journal of biological chemistry, 275(10), 6819–6823.PubMed
73.
go back to reference Fairweather, D., Frisancho-Kiss, S., Yusung, S. A., Barrett, M. A., Davis, S. E., Steele, R. A., et al. (2005). IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart. Journal of Immunology, 174(1), 261–269. Fairweather, D., Frisancho-Kiss, S., Yusung, S. A., Barrett, M. A., Davis, S. E., Steele, R. A., et al. (2005). IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart. Journal of Immunology, 174(1), 261–269.
74.
go back to reference Grabie, N., Hsieh, D. T., Buono, C., Westrich, J. R., Allen, J. A., Pang, H., et al. (2003). Neutrophils sustain pathogenic CD8+ T cell responses in the heart. The American journal of pathology, 163(6), 2413–2420. doi:10.1016/S0002-9440(10)63596-1.PubMed Grabie, N., Hsieh, D. T., Buono, C., Westrich, J. R., Allen, J. A., Pang, H., et al. (2003). Neutrophils sustain pathogenic CD8+ T cell responses in the heart. The American journal of pathology, 163(6), 2413–2420. doi:10.​1016/​S0002-9440(10)63596-1.PubMed
75.
go back to reference Dulon, S., Cande, C., Bunnett, N. W., Hollenberg, M. D., Chignard, M., & Pidard, D. (2003). Proteinase-activated receptor-2 and human lung epithelial cells: disarming by neutrophil serine proteinases. American journal of respiratory cell and molecular biology, 28(3), 339–346. doi:10.1165/rcmb.4908.PubMed Dulon, S., Cande, C., Bunnett, N. W., Hollenberg, M. D., Chignard, M., & Pidard, D. (2003). Proteinase-activated receptor-2 and human lung epithelial cells: disarming by neutrophil serine proteinases. American journal of respiratory cell and molecular biology, 28(3), 339–346. doi:10.​1165/​rcmb.​4908.PubMed
76.
go back to reference Suzuki, T., Yamashita, C., Zemans, R. L., Briones, N., Van Linden, A., & Downey, G. P. (2009). Leukocyte elastase induces lung epithelial apoptosis via a PAR-1-, NF-kappaB-, and p53-dependent pathway. American journal of respiratory cell and molecular biology, 41(6), 742–755. doi:10.1165/rcmb.2008-0157OC.PubMed Suzuki, T., Yamashita, C., Zemans, R. L., Briones, N., Van Linden, A., & Downey, G. P. (2009). Leukocyte elastase induces lung epithelial apoptosis via a PAR-1-, NF-kappaB-, and p53-dependent pathway. American journal of respiratory cell and molecular biology, 41(6), 742–755. doi:10.​1165/​rcmb.​2008-0157OC.PubMed
77.
go back to reference Lee, J. K., Zaidi, S. H., Liu, P., Dawood, F., Cheah, A. Y., Wen, W. H., et al. (1998). A serine elastase inhibitor reduces inflammation and fibrosis and preserves cardiac function after experimentally-induced murine myocarditis. Nature medicine, 4(12), 1383–1391. doi:10.1038/3973.PubMed Lee, J. K., Zaidi, S. H., Liu, P., Dawood, F., Cheah, A. Y., Wen, W. H., et al. (1998). A serine elastase inhibitor reduces inflammation and fibrosis and preserves cardiac function after experimentally-induced murine myocarditis. Nature medicine, 4(12), 1383–1391. doi:10.​1038/​3973.PubMed
80.
go back to reference Yang, E., Boire, A., Agarwal, A., Nguyen, N., O’Callaghan, K., Tu, P., et al. (2009). Blockade of PAR1 signaling with cell-penetrating pepducins inhibits Akt survival pathways in breast cancer cells and suppresses tumor survival and metastasis. Cancer research, 69(15), 6223–6231. doi:10.1158/0008-5472.CAN-09-0187.PubMedCentralPubMed Yang, E., Boire, A., Agarwal, A., Nguyen, N., O’Callaghan, K., Tu, P., et al. (2009). Blockade of PAR1 signaling with cell-penetrating pepducins inhibits Akt survival pathways in breast cancer cells and suppresses tumor survival and metastasis. Cancer research, 69(15), 6223–6231. doi:10.​1158/​0008-5472.​CAN-09-0187.PubMedCentralPubMed
81.
go back to reference Sharma, R., Prasad, V., McCarthy, E. T., Savin, V. J., Dileepan, K. N., Stechschulte, D. J., et al. (2007). Chymase increases glomerular albumin permeability via protease-activated receptor-2. Molecular and cellular biochemistry, 297(1–2), 161–169. doi:10.1007/s11010-006-9342-0.PubMed Sharma, R., Prasad, V., McCarthy, E. T., Savin, V. J., Dileepan, K. N., Stechschulte, D. J., et al. (2007). Chymase increases glomerular albumin permeability via protease-activated receptor-2. Molecular and cellular biochemistry, 297(1–2), 161–169. doi:10.​1007/​s11010-006-9342-0.PubMed
82.
go back to reference Molino, M., Barnathan, E. S., Numerof, R., Clark, J., Dreyer, M., Cumashi, A., et al. (1997). Interactions of mast cell tryptase with thrombin receptors and PAR-2. The Journal of biological chemistry, 272(7), 4043–4049.PubMed Molino, M., Barnathan, E. S., Numerof, R., Clark, J., Dreyer, M., Cumashi, A., et al. (1997). Interactions of mast cell tryptase with thrombin receptors and PAR-2. The Journal of biological chemistry, 272(7), 4043–4049.PubMed
83.
go back to reference Fairweather, D., Frisancho-Kiss, S., Gatewood, S., Njoku, D., Steele, R., Barrett, M., et al. (2004). Mast cells and innate cytokines are associated with susceptibility to autoimmune heart disease following coxsackievirus B3 infection. Autoimmunity, 37(2), 131–145.PubMed Fairweather, D., Frisancho-Kiss, S., Gatewood, S., Njoku, D., Steele, R., Barrett, M., et al. (2004). Mast cells and innate cytokines are associated with susceptibility to autoimmune heart disease following coxsackievirus B3 infection. Autoimmunity, 37(2), 131–145.PubMed
85.
go back to reference Gan, X., Liu, D., Huang, P., Gao, W., Chen, X., & Hei, Z. (2012). Mast-cell-releasing tryptase triggers acute lung injury induced by small intestinal ischemia-reperfusion by activating PAR-2 in rats. Inflammation, 35(3), 1144–1153. doi:10.1007/s10753-011-9422-5.PubMed Gan, X., Liu, D., Huang, P., Gao, W., Chen, X., & Hei, Z. (2012). Mast-cell-releasing tryptase triggers acute lung injury induced by small intestinal ischemia-reperfusion by activating PAR-2 in rats. Inflammation, 35(3), 1144–1153. doi:10.​1007/​s10753-011-9422-5.PubMed
86.
go back to reference He, S., Aslam, A., Gaca, M. D., He, Y., Buckley, M. G., Hollenberg, M. D., et al. (2004). Inhibitors of tryptase as mast cell-stabilizing agents in the human airways: effects of tryptase and other agonists of proteinase-activated receptor 2 on histamine release. The Journal of pharmacology and experimental therapeutics, 309(1), 119–126. doi:10.1124/jpet.103.061291.PubMed He, S., Aslam, A., Gaca, M. D., He, Y., Buckley, M. G., Hollenberg, M. D., et al. (2004). Inhibitors of tryptase as mast cell-stabilizing agents in the human airways: effects of tryptase and other agonists of proteinase-activated receptor 2 on histamine release. The Journal of pharmacology and experimental therapeutics, 309(1), 119–126. doi:10.​1124/​jpet.​103.​061291.PubMed
87.
go back to reference Bazan, J. F., & Fletterick, R. J. (1988). Viral cysteine proteases are homologous to the trypsin-like family of serine proteases: structural and functional implications. Proceedings of the National Academy of Sciences of the United States of America, 85(21), 7872–7876.PubMedCentralPubMed Bazan, J. F., & Fletterick, R. J. (1988). Viral cysteine proteases are homologous to the trypsin-like family of serine proteases: structural and functional implications. Proceedings of the National Academy of Sciences of the United States of America, 85(21), 7872–7876.PubMedCentralPubMed
89.
go back to reference Liang, G., Barker, T., Xie, Z., Charles, N., Rivera, J., & Druey, K. M. (2012). Naive T cells sense the cysteine protease allergen papain through protease-activated receptor 2 and propel TH2 immunity. The Journal of allergy and clinical immunology, 129(5), 1377–1386 e1313. doi:10.1016/j.jaci.2012.02.035.PubMedCentralPubMed Liang, G., Barker, T., Xie, Z., Charles, N., Rivera, J., & Druey, K. M. (2012). Naive T cells sense the cysteine protease allergen papain through protease-activated receptor 2 and propel TH2 immunity. The Journal of allergy and clinical immunology, 129(5), 1377–1386 e1313. doi:10.​1016/​j.​jaci.​2012.​02.​035.PubMedCentralPubMed
90.
go back to reference Xing, Y., Chen, J., Tu, J., Zhang, B., Chen, X., Shi, H., et al. (2013). The papain-like protease of porcine epidemic diarrhea virus negatively regulates type I interferon pathway by acting as a viral deubiquitinase. The Journal of general virology, 94(Pt 7), 1554–1567. doi:10.1099/vir.0.051169-0.PubMed Xing, Y., Chen, J., Tu, J., Zhang, B., Chen, X., Shi, H., et al. (2013). The papain-like protease of porcine epidemic diarrhea virus negatively regulates type I interferon pathway by acting as a viral deubiquitinase. The Journal of general virology, 94(Pt 7), 1554–1567. doi:10.​1099/​vir.​0.​051169-0.PubMed
92.
94.
go back to reference Sutherland, M. R., Ruf, W., & Pryzdial, E. L. (2012). Tissue factor and glycoprotein C on herpes simplex virus type 1 are protease-activated receptor 2 cofactors that enhance infection. Blood, 119(15), 3638–3645. doi:10.1182/blood-2011-08-376814.PubMed Sutherland, M. R., Ruf, W., & Pryzdial, E. L. (2012). Tissue factor and glycoprotein C on herpes simplex virus type 1 are protease-activated receptor 2 cofactors that enhance infection. Blood, 119(15), 3638–3645. doi:10.​1182/​blood-2011-08-376814.PubMed
95.
go back to reference Weithaeuser, A., Bobbert, P., Antoniak, S., Boehm, A., Rauch, B.H., Klingel, K., Savvatis, K., Kroemer, H.K., Tschope, C., Stroux, A., Zeichhardt, H., Poller, W., Mackman, N., Schultheiss, H.P., Rauch, U. (2013). Protease-activated receptor 2 regulates the Innate Immune Response to Viral Infection in a CVB3-induced Myocarditis. Journal of the American College of Cardiology, 62(19), 1737–1745. doi:10.1016/j.jacc.2013.05.076. Weithaeuser, A., Bobbert, P., Antoniak, S., Boehm, A., Rauch, B.H., Klingel, K., Savvatis, K., Kroemer, H.K., Tschope, C., Stroux, A., Zeichhardt, H., Poller, W., Mackman, N., Schultheiss, H.P., Rauch, U. (2013). Protease-activated receptor 2 regulates the Innate Immune Response to Viral Infection in a CVB3-induced Myocarditis. Journal of the American College of Cardiology, 62(19), 1737–1745. doi:10.​1016/​j.​jacc.​2013.​05.​076.​
96.
go back to reference Nhu, Q. M., Shirey, K., Teijaro, J. R., Farber, D. L., Netzel-Arnett, S., Antalis, T. M., et al. (2010). Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo. Mucosal immunology, 3(1), 29–39. doi:10.1038/mi.2009.120.PubMedCentralPubMed Nhu, Q. M., Shirey, K., Teijaro, J. R., Farber, D. L., Netzel-Arnett, S., Antalis, T. M., et al. (2010). Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo. Mucosal immunology, 3(1), 29–39. doi:10.​1038/​mi.​2009.​120.PubMedCentralPubMed
97.
go back to reference Rallabhandi, P., Nhu, Q. M., Toshchakov, V. Y., Piao, W., Medvedev, A. E., Hollenberg, M. D., et al. (2008). Analysis of proteinase-activated receptor 2 and TLR4 signal transduction: a novel paradigm for receptor cooperativity. The Journal of biological chemistry, 283(36), 24314–24325. doi:10.1074/jbc.M804800200.PubMed Rallabhandi, P., Nhu, Q. M., Toshchakov, V. Y., Piao, W., Medvedev, A. E., Hollenberg, M. D., et al. (2008). Analysis of proteinase-activated receptor 2 and TLR4 signal transduction: a novel paradigm for receptor cooperativity. The Journal of biological chemistry, 283(36), 24314–24325. doi:10.​1074/​jbc.​M804800200.PubMed
98.
99.
go back to reference Eriksson, U., Ricci, R., Hunziker, L., Kurrer, M. O., Oudit, G. Y., Watts, T. H., et al. (2003). Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nature medicine, 9(12), 1484–1490. doi:10.1038/nm960.PubMed Eriksson, U., Ricci, R., Hunziker, L., Kurrer, M. O., Oudit, G. Y., Watts, T. H., et al. (2003). Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nature medicine, 9(12), 1484–1490. doi:10.​1038/​nm960.PubMed
100.
go back to reference Fuse, K., Chan, G., Liu, Y., Gudgeon, P., Husain, M., Chen, M., et al. (2005). Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production. Circulation, 112(15), 2276–2285. doi:10.1161/CIRCULATIONAHA.105.536433.PubMed Fuse, K., Chan, G., Liu, Y., Gudgeon, P., Husain, M., Chen, M., et al. (2005). Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production. Circulation, 112(15), 2276–2285. doi:10.​1161/​CIRCULATIONAHA.​105.​536433.PubMed
101.
go back to reference Frisancho-Kiss, S., Davis, S. E., Nyland, J. F., Frisancho, J. A., Cihakova, D., Barrett, M. A., et al. (2007). Cutting edge: cross-regulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease. Journal of Immunology, 178(11), 6710–6714. Frisancho-Kiss, S., Davis, S. E., Nyland, J. F., Frisancho, J. A., Cihakova, D., Barrett, M. A., et al. (2007). Cutting edge: cross-regulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease. Journal of Immunology, 178(11), 6710–6714.
102.
go back to reference Roberts, B. J., Dragon, J. A., Moussawi, M., & Huber, S. A. (2012). Sex-specific signaling through Toll-Like receptors 2 and 4 contributes to survival outcome of coxsackievirus B3 infection in C57Bl/6 mice. Biology of sex differences, 3(1), 25. doi:10.1186/2042-6410-3-25.PubMedCentralPubMed Roberts, B. J., Dragon, J. A., Moussawi, M., & Huber, S. A. (2012). Sex-specific signaling through Toll-Like receptors 2 and 4 contributes to survival outcome of coxsackievirus B3 infection in C57Bl/6 mice. Biology of sex differences, 3(1), 25. doi:10.​1186/​2042-6410-3-25.PubMedCentralPubMed
104.
105.
106.
go back to reference Sabri, A., Guo, J., Elouardighi, H., Darrow, A. L., Andrade-Gordon, P., & Steinberg, S. F. (2003). Mechanisms of protease-activated receptor-4 actions in cardiomyocytes. Role of Src tyrosine kinase. The Journal of biological chemistry, 278(13), 11714–11720. doi:10.1074/jbc.M213091200.PubMed Sabri, A., Guo, J., Elouardighi, H., Darrow, A. L., Andrade-Gordon, P., & Steinberg, S. F. (2003). Mechanisms of protease-activated receptor-4 actions in cardiomyocytes. Role of Src tyrosine kinase. The Journal of biological chemistry, 278(13), 11714–11720. doi:10.​1074/​jbc.​M213091200.PubMed
107.
go back to reference Meune, C., Spaulding, C., Mahe, I., Lebon, P., & Bergmann, J. F. (2003). Risks versus benefits of NSAIDs including aspirin in myocarditis: a review of the evidence from animal studies. Drug safety : an international journal of medical toxicology and drug experience, 26(13), 975–981. Meune, C., Spaulding, C., Mahe, I., Lebon, P., & Bergmann, J. F. (2003). Risks versus benefits of NSAIDs including aspirin in myocarditis: a review of the evidence from animal studies. Drug safety : an international journal of medical toxicology and drug experience, 26(13), 975–981.
108.
go back to reference Eyers, S., Weatherall, M., Shirtcliffe, P., Perrin, K., & Beasley, R. (2010). The effect on mortality of antipyretics in the treatment of influenza infection: systematic review and meta-analysis. Journal of the Royal Society of Medicine, 103(10), 403–411. doi:10.1258/jrsm.2010.090441.PubMedCentralPubMed Eyers, S., Weatherall, M., Shirtcliffe, P., Perrin, K., & Beasley, R. (2010). The effect on mortality of antipyretics in the treatment of influenza infection: systematic review and meta-analysis. Journal of the Royal Society of Medicine, 103(10), 403–411. doi:10.​1258/​jrsm.​2010.​090441.PubMedCentralPubMed
109.
go back to reference Shimazu, T. (2009). A/H1N1 flu. Aspirin in the 1918 pandemic. BMJ, 338, b2398.PubMed Shimazu, T. (2009). A/H1N1 flu. Aspirin in the 1918 pandemic. BMJ, 338, b2398.PubMed
110.
go back to reference Starko, K. M. (2009). Salicylates and pandemic influenza mortality, 1918–1919 pharmacology, pathology, and historic evidence. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 49(9), 1405–1410. doi:10.1086/606060. Starko, K. M. (2009). Salicylates and pandemic influenza mortality, 1918–1919 pharmacology, pathology, and historic evidence. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 49(9), 1405–1410. doi:10.​1086/​606060.
111.
go back to reference Weitz, J. I., & Gross, P. L. (2012). New oral anticoagulants: which one should my patient use? Hematology / the Education Program of the American Society of Hematology American Society of Hematology Education Program, 2012, 536–540. doi:10.1182/asheducation-2012.1.536.PubMed Weitz, J. I., & Gross, P. L. (2012). New oral anticoagulants: which one should my patient use? Hematology / the Education Program of the American Society of Hematology American Society of Hematology Education Program, 2012, 536–540. doi:10.​1182/​asheducation-2012.​1.​536.PubMed
112.
113.
go back to reference Malz, R., Becher, M., Westermann, D., Schultheiss, H.P., Rauch, U. (2012). Inhibition of coagulation factor Xa improves left ventricular function during CVB3-induced myocarditis [abstract]. Paper presented at the 78. Jahrestagung der DGK, 2012 Malz, R., Becher, M., Westermann, D., Schultheiss, H.P., Rauch, U. (2012). Inhibition of coagulation factor Xa improves left ventricular function during CVB3-induced myocarditis [abstract]. Paper presented at the 78. Jahrestagung der DGK, 2012
115.
go back to reference Lohman, R. J., Cotterell, A. J., Barry, G. D., Liu, L., Suen, J. Y., Vesey, D. A., et al. (2012). An antagonist of human protease activated receptor-2 attenuates PAR2 signaling, macrophage activation, mast cell degranulation, and collagen-induced arthritis in rats. The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 26(7), 2877–2887. doi:10.1096/fj.11-201004. Lohman, R. J., Cotterell, A. J., Barry, G. D., Liu, L., Suen, J. Y., Vesey, D. A., et al. (2012). An antagonist of human protease activated receptor-2 attenuates PAR2 signaling, macrophage activation, mast cell degranulation, and collagen-induced arthritis in rats. The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 26(7), 2877–2887. doi:10.​1096/​fj.​11-201004.
116.
go back to reference Sevigny, L. M., Zhang, P., Bohm, A., Lazarides, K., Perides, G., Covic, L., et al. (2011). Interdicting protease-activated receptor-2-driven inflammation with cell-penetrating pepducins. Proceedings of the National Academy of Sciences of the United States of America, 108(20), 8491–8496. doi:10.1073/pnas.1017091108.PubMedCentralPubMed Sevigny, L. M., Zhang, P., Bohm, A., Lazarides, K., Perides, G., Covic, L., et al. (2011). Interdicting protease-activated receptor-2-driven inflammation with cell-penetrating pepducins. Proceedings of the National Academy of Sciences of the United States of America, 108(20), 8491–8496. doi:10.​1073/​pnas.​1017091108.PubMedCentralPubMed
Metadata
Title
Coagulation, Protease-Activated Receptors, and Viral Myocarditis
Authors
Silvio Antoniak
Nigel Mackman
Publication date
01-03-2014
Publisher
Springer US
Published in
Journal of Cardiovascular Translational Research / Issue 2/2014
Print ISSN: 1937-5387
Electronic ISSN: 1937-5395
DOI
https://doi.org/10.1007/s12265-013-9515-7

Other articles of this Issue 2/2014

Journal of Cardiovascular Translational Research 2/2014 Go to the issue